Annual D&A
$528.00 K
-$128.00 K-19.51%
31 December 2023
Summary:
Intra-Cellular Therapies annual depreciation & amortization is currently $528.00 thousand, with the most recent change of -$128.00 thousand (-19.51%) on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). ITCI annual D&A is now -19.51% below its all-time high of $656.00 thousand, reached on 31 December 2022.ITCI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$138.00 K
+$9000.00+6.98%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly depreciation & amortization is currently $138.00 thousand, with the most recent change of +$9000.00 (+6.98%) on 30 September 2024. Over the past year, it has increased by +$3000.00 (+2.22%). ITCI quarterly D&A is now -19.77% below its all-time high of $172.00 thousand, reached on 30 June 2022.ITCI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$535.00 K
+$3000.00+0.56%
30 September 2024
Summary:
Intra-Cellular Therapies TTM depreciation & amortization is currently $535.00 thousand, with the most recent change of +$3000.00 (+0.56%) on 30 September 2024. Over the past year, it has stayed the same.ITCI TTM D&A is now -18.82% below its all-time high of $659.00 thousand, reached on 30 September 2022.ITCI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.5% | +2.2% | 0.0% |
| 3 y3 years | 0.0% | +3.0% | +4.3% |
| 5 y5 years | +43.2% | +6.9% | +24.1% |
ITCI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.5% | at low | -19.8% | +12.2% | -18.8% | +4.3% |
| 5 y | 5 years | -19.5% | +43.2% | -19.8% | +14.1% | -18.8% | +24.1% |
| alltime | all time | -19.5% | +2175.9% | -19.8% | +2090.5% | -18.8% | +8392.1% |
Intra-Cellular Therapies Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $138.00 K(+7.0%) | $535.00 K(+0.6%) |
| June 2024 | - | $129.00 K(-2.3%) | $532.00 K(+1.1%) |
| Mar 2024 | - | $132.00 K(-2.9%) | $526.00 K(-0.4%) |
| Dec 2023 | $528.00 K(-19.5%) | $136.00 K(+0.7%) | $528.00 K(-1.3%) |
| Sept 2023 | - | $135.00 K(+9.8%) | $535.00 K(-6.1%) |
| June 2023 | - | $123.00 K(-8.2%) | $570.00 K(-7.9%) |
| Mar 2023 | - | $134.00 K(-6.3%) | $619.00 K(-5.6%) |
| Dec 2022 | $656.00 K(+23.1%) | $143.00 K(-15.9%) | $656.00 K(-0.5%) |
| Sept 2022 | - | $170.00 K(-1.2%) | $659.00 K(+5.8%) |
| June 2022 | - | $172.00 K(+0.6%) | $623.00 K(+8.0%) |
| Mar 2022 | - | $171.00 K(+17.1%) | $577.00 K(+8.3%) |
| Dec 2021 | $533.00 K(+0.9%) | $146.00 K(+9.0%) | $533.00 K(+3.9%) |
| Sept 2021 | - | $134.00 K(+6.3%) | $512.90 K(+2.6%) |
| June 2021 | - | $126.00 K(-0.8%) | $499.90 K(-1.2%) |
| Mar 2021 | - | $127.00 K(+0.9%) | $506.20 K(-4.1%) |
| Dec 2020 | $528.00 K(+10.7%) | $125.90 K(+4.0%) | $528.00 K(-2.9%) |
| Sept 2020 | - | $121.00 K(-8.5%) | $543.80 K(-1.5%) |
| June 2020 | - | $132.30 K(-11.1%) | $551.90 K(+5.2%) |
| Mar 2020 | - | $148.80 K(+5.0%) | $524.70 K(+9.9%) |
| Dec 2019 | $477.10 K | $141.70 K(+9.8%) | $477.30 K(+10.7%) |
| Sept 2019 | - | $129.10 K(+22.8%) | $431.10 K(+8.6%) |
| June 2019 | - | $105.10 K(+3.6%) | $396.90 K(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $101.40 K(+6.2%) | $387.60 K(+5.1%) |
| Dec 2018 | $368.70 K(+72.4%) | $95.50 K(+0.6%) | $368.70 K(+11.1%) |
| Sept 2018 | - | $94.90 K(-0.9%) | $331.80 K(+14.3%) |
| June 2018 | - | $95.80 K(+16.1%) | $290.40 K(+18.0%) |
| Mar 2018 | - | $82.50 K(+40.8%) | $246.00 K(+15.0%) |
| Dec 2017 | $213.90 K(+8.6%) | $58.60 K(+9.5%) | $213.90 K(+4.1%) |
| Sept 2017 | - | $53.50 K(+4.1%) | $205.40 K(+1.7%) |
| June 2017 | - | $51.40 K(+2.0%) | $202.00 K(+1.4%) |
| Mar 2017 | - | $50.40 K(+0.6%) | $199.30 K(+1.2%) |
| Dec 2016 | $196.90 K(+41.0%) | $50.10 K(0.0%) | $196.90 K(+1.6%) |
| Sept 2016 | - | $50.10 K(+2.9%) | $193.80 K(+2.4%) |
| June 2016 | - | $48.70 K(+1.5%) | $189.20 K(+9.7%) |
| Mar 2016 | - | $48.00 K(+2.1%) | $172.40 K(+23.5%) |
| Dec 2015 | $139.60 K(+447.5%) | $47.00 K(+3.3%) | $139.60 K(+41.2%) |
| Sept 2015 | - | $45.50 K(+42.6%) | $98.90 K(+65.4%) |
| June 2015 | - | $31.90 K(+109.9%) | $59.80 K(+74.3%) |
| Mar 2015 | - | $15.20 K(+141.3%) | $34.30 K(+35.0%) |
| Dec 2014 | $25.50 K(+9.9%) | $6300.00(-1.6%) | $25.40 K(+33.0%) |
| Sept 2014 | - | $6400.00(0.0%) | $19.10 K(+50.4%) |
| June 2014 | - | $6400.00(+1.6%) | $12.70 K(+101.6%) |
| Mar 2014 | - | $6300.00 | $6300.00 |
| Dec 2013 | $23.20 K(-51.4%) | - | - |
| Dec 2012 | $47.70 K | - | - |
FAQ
- What is Intra-Cellular Therapies annual depreciation & amortization?
- What is the all time high annual D&A for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual D&A year-on-year change?
- What is Intra-Cellular Therapies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly D&A year-on-year change?
- What is Intra-Cellular Therapies TTM depreciation & amortization?
- What is the all time high TTM D&A for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM D&A year-on-year change?
What is Intra-Cellular Therapies annual depreciation & amortization?
The current annual D&A of ITCI is $528.00 K
What is the all time high annual D&A for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual depreciation & amortization is $656.00 K
What is Intra-Cellular Therapies annual D&A year-on-year change?
Over the past year, ITCI annual depreciation & amortization has changed by -$128.00 K (-19.51%)
What is Intra-Cellular Therapies quarterly depreciation & amortization?
The current quarterly D&A of ITCI is $138.00 K
What is the all time high quarterly D&A for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly depreciation & amortization is $172.00 K
What is Intra-Cellular Therapies quarterly D&A year-on-year change?
Over the past year, ITCI quarterly depreciation & amortization has changed by +$3000.00 (+2.22%)
What is Intra-Cellular Therapies TTM depreciation & amortization?
The current TTM D&A of ITCI is $535.00 K
What is the all time high TTM D&A for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM depreciation & amortization is $659.00 K
What is Intra-Cellular Therapies TTM D&A year-on-year change?
Over the past year, ITCI TTM depreciation & amortization has changed by $0.00 (0.00%)